Favorites Sign in
  1. Home
  2. Companies
  3. Stock Amphastar Pharmaceuticals
Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals AMPH

$ 28.0 3.4%
report update icon

Quarterly report 2026-Q2
added 08-06-2026

Country

 usaUSA

IPO year

 2014

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 46.7 M

Market Cap[1]

 $ 1.31 B

EBITDA (LTM)

 $ 172 M

P/E (LTM)

 11.038095

P/S (LTM)

 1.505101

EPS (LTM)

 2.1

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Catabasis Pharmaceuticals, Inc. Catabasis Pharmaceuticals, Inc.
CATB
 		- -6.97 % $ 657 M Nasdaq Global Market usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
 		$ 8.81 6.92 % $ 409 M Nasdaq Capital Market usaUSA
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
 		- 1.68 % $ 4.65 B Nasdaq Global Select Market chinaChina
Jazz Pharmaceuticals plc Jazz Pharmaceuticals plc
JAZZ
 		$ 234.59 2.11 % $ 14.3 B Nasdaq Global Select Market irlandaIrlanda
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		$ 3.78 -2.58 % $ 404 M Nasdaq Global Market usaUSA
Arvinas Arvinas
ARVN
 		$ 7.41 4.51 % $ 525 M Nasdaq Global Select Market,SPB usaUSA
Cerus Corporation Cerus Corporation
CERS
 		$ 2.44 4.06 % $ 465 M Nasdaq Global Market usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
 		$ 27.76 5.41 % $ 2.75 B Nasdaq Global Select Market usaUSA
Fortress Biotech Fortress Biotech
FBIO
 		$ 1.97 1.55 % $ 55 M Nasdaq Capital Market usaUSA
Inhibrx Inhibrx
INBX
 		$ 86.79 7.04 % $ 4.09 B Nasdaq Global Select Market usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
 		$ 3.17 3.93 % $ 146 M Nasdaq Capital Market israelIsrael
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
 		- - $ 459 M Nasdaq Global Market usaUSA
Legend Biotech Corporation Legend Biotech Corporation
LEGN
 		$ 22.8 6.12 % $ 8.41 B Nasdaq Global Select Market usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
 		$ 2.35 7.57 % $ 324 M Nasdaq Global Select Market usaUSA
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
 		$ 316.11 0.82 % $ 6.11 B Nasdaq Global Select Market,SPB usaUSA
Longeveron Longeveron
LGVN
 		$ 1.81 1.69 % $ 31.8 B Nasdaq Global Select Market usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
 		$ 1.57 5.74 % $ 154 M Nasdaq Capital Market usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
 		$ 0.3 3.65 % $ 50 M Nasdaq Global Select Market,SPB usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
 		$ 1.63 -1.81 % $ 76.4 M Nasdaq Global Select Market usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
 		$ 10.57 7.53 % $ 835 M Nasdaq Global Market usaUSA
Aytu BioScience Aytu BioScience
AYTU
 		$ 1.9 -1.55 % $ 23.4 M Nasdaq Capital Market usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		- -5.76 % $ 99.8 M Nasdaq Capital Market usaUSA
Innoviva Innoviva
INVA
 		$ 21.26 1.58 % $ 1.43 B Nasdaq Global Select Market usaUSA
BioCardia BioCardia
BCDA
 		$ 0.91 -1.26 % $ 6.07 M Nasdaq Global Select Market usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
 		- 0.11 % $ 419 M Nasdaq Global Select Market usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		$ 2.5 1.21 % $ 16 B Nasdaq Capital Market australiaAustralia
Shineco, Inc. Shineco, Inc.
TYHT
 		- -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.
MLND
 		- -5.36 % $ 20.2 M Nasdaq Global Select Market usaUSA
Certara Certara
CERT
 		$ 11.09 1.98 % $ 1.78 B Nasdaq Global Select Market usaUSA
Dyadic International Dyadic International
DYAI
 		$ 0.37 1.44 % $ 13.4 M Nasdaq Capital Market usaUSA
Intec Pharma Ltd Intec Pharma Ltd
NTEC
 		- -12.45 % $ 17.7 M Nasdaq Capital Market israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
 		$ 20.37 4.73 % $ 292 M Nasdaq Global Select Market,SPB usaUSA
Aprea Therapeutics Aprea Therapeutics
APRE
 		$ 0.51 -1.59 % $ 3.33 M Nasdaq Global Select Market,SPB usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
 		$ 3.49 4.18 % $ 223 M Nasdaq Global Select Market usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
 		$ 79.1 -3.45 % $ 8.22 B Nasdaq Capital Market,SPB usaUSA
Progenity, Inc. Progenity, Inc.
PROG
 		- -3.47 % $ 164 M Nasdaq Global Select Market usaUSA
Genprex Genprex
GNPX
 		$ 2.16 -6.49 % $ 2.01 M Nasdaq Capital Market usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
 		- 1.52 % $ 136 M Nasdaq Global Select Market usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
 		$ 1.43 7.14 % $ 128 M Nasdaq Global Select Market franceFrance
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
 		- -1.19 % $ 28.7 M Nasdaq Capital Market usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
 		$ 57.15 2.68 % $ 11 B Nasdaq Global Select Market,SPB usaUSA
Matinas BioPharma Holdings Matinas BioPharma Holdings
MTNB
 		$ 1.16 3.12 % $ 6.35 M NYSE American usaUSA
Enanta Pharmaceuticals Enanta Pharmaceuticals
ENTA
 		$ 10.69 3.09 % $ 228 K Nasdaq Global Select Market,SPB usaUSA
Milestone Pharmaceuticals Milestone Pharmaceuticals
MIST
 		$ 0.78 3.19 % $ 82.9 M Nasdaq Global Select Market canadaCanada
Kiniksa Pharmaceuticals, Ltd. Kiniksa Pharmaceuticals, Ltd.
KNSA
 		$ 95.5 2.37 % $ 7.09 B Nasdaq Global Select Market usaUSA
Lipocine Lipocine
LPCN
 		$ 1.43 -2.05 % $ 7.79 M Nasdaq Global Select Market usaUSA
Seres Therapeutics Seres Therapeutics
MCRB
 		$ 2.11 7.65 % $ 18.7 M Nasdaq Global Select Market usaUSA
Madrigal Pharmaceuticals Madrigal Pharmaceuticals
MDGL
 		$ 400.41 1.03 % $ 8.98 B Nasdaq Global Select Market,SPB usaUSA
Mesoblast Limited Mesoblast Limited
MESO
 		$ 14.3 -3.18 % $ 17.3 B Nasdaq Global Select Market australiaAustralia

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.